BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30590590)

  • 1. Factors Affecting Clinical and Endoscopic Outcomes of Placebo Arm in Trials of Biologics and Small Molecule Drugs in Ulcerative Colitis: A Meta-Analysis.
    Macaluso FS; Maida M; Ventimiglia M; Renna S; Cottone M; Orlando A
    Inflamm Bowel Dis; 2019 May; 25(6):987-997. PubMed ID: 30590590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo response and remission rates in randomised trials of induction and maintenance therapy for ulcerative colitis.
    Jairath V; Zou GY; Parker CE; MacDonald JK; AlAmeel T; Al Beshir M; Almadi MA; Al-Taweel T; Atkinson NS; Biswas S; Chapman T; Dulai PS; Glaire MA; Hoekman DR; Koutsoumpas A; Minas E; Mosli MH; Samaan M; Khanna R; Travis S; D'Haens G; Sandborn WJ; Feagan BG
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011572. PubMed ID: 28886205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review with meta-analysis: endoscopic and histologic placebo rates in induction and maintenance trials of ulcerative colitis.
    Ma C; Guizzetti L; Panaccione R; Fedorak RN; Pai RK; Parker CE; Nguyen TM; Khanna R; Vande Casteele N; D'Haens G; Sandborn WJ; Feagan BG; Jairath V
    Aliment Pharmacol Ther; 2018 Jun; 47(12):1578-1596. PubMed ID: 29696670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of the placebo rates of remission and response in clinical trials of active ulcerative colitis.
    Su C; Lewis JD; Goldberg B; Brensinger C; Lichtenstein GR
    Gastroenterology; 2007 Feb; 132(2):516-26. PubMed ID: 17258720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials.
    Cholapranee A; Hazlewood GS; Kaplan GG; Peyrin-Biroulet L; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2017 May; 45(10):1291-1302. PubMed ID: 28326566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histological Remission Placebo Rates in Ulcerative Colitis Trials: A Systematic Review and Meta-analysis.
    Youssef M; Dong K; Lee SJ; Narula N
    Inflamm Bowel Dis; 2024 Jan; 30(1):125-131. PubMed ID: 36753516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral budesonide for induction of remission in ulcerative colitis.
    Sherlock ME; Seow CH; Steinhart AH; Griffiths AM
    Cochrane Database Syst Rev; 2010 Oct; (10):CD007698. PubMed ID: 20927762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histologic Healing Rates of Medical Therapies for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Battat R; Duijvestein M; Guizzetti L; Choudhary D; Boland BS; Dulai PS; Parker CE; Nguyen TM; Singh S; Vande Casteele N; Pai RK; Feagan BG; Sandborn WJ; Jairath V
    Am J Gastroenterol; 2019 May; 114(5):733-745. PubMed ID: 30694863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-Analysis: Clinical, Endoscopic, Histological and Safety Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
    Sedano R; Hogan M; Nguyen TM; Chang J; Zou GY; Macdonald JK; Vande Casteele N; Hanzel J; Crowley E; Battat R; Dulai PS; Singh S; D'Haens G; Sandborn W; Feagan BG; Ma C; Jairath V
    J Crohns Colitis; 2022 Feb; 16(2):224-243. PubMed ID: 34309658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic and Histological Placebo Rates in Crohn's Disease Clinical Trials: A Systematic Review and Meta-analysis.
    Vuyyuru SK; Nguyen TM; Hogan M; Raine T; Noor NM; Narula N; Verstockt B; Feagan BG; Singh S; Ma C; Jairath V
    Inflamm Bowel Dis; 2024 Apr; 30(4):651-659. PubMed ID: 37002875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis.
    Jairath V; Zou G; Parker CE; Macdonald JK; Mosli MH; Khanna R; Shackelton LM; Vandervoort MK; AlAmeel T; Al Beshir M; AlMadi M; Al-Taweel T; Atkinson NS; Biswas S; Chapman TP; Dulai PS; Glaire MA; Hoekman D; Koutsoumpas A; Minas E; Samaan MA; Travis S; D'Haens G; Levesque BG; Sandborn WJ; Feagan BG
    J Crohns Colitis; 2016 May; 10(5):607-18. PubMed ID: 26746169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vedolizumab for induction and maintenance of remission in ulcerative colitis.
    Bickston SJ; Behm BW; Tsoulis DJ; Cheng J; MacDonald JK; Khanna R; Feagan BG
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007571. PubMed ID: 25105240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting clinical and endoscopic remission with placebo therapy in East Asian patients with ulcerative colitis: a systematic review and meta-analysis.
    Zeng J; Wang Z; Yang XJ
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1069-1077. PubMed ID: 35347342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I interferons for induction of remission in ulcerative colitis.
    Seow CH; Benchimol EI; Griffiths AM; Steinhart AH
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006790. PubMed ID: 18646167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal nicotine for induction of remission in ulcerative colitis.
    McGrath J; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004722. PubMed ID: 15495126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving primary and secondary endpoints in randomized controlled trials leading to approval of biologics and small molecules in IBD: an historical perspective.
    Allen PB; Bonovas S; Danese S; Peyrin-Biroulet L
    Expert Opin Biol Ther; 2020 Feb; 20(2):151-161. PubMed ID: 31815548
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.